Yes
Myelofibrosis can progress to acute lymphocytic leukemia or lymphoma
Yes
Leukemia is classified primarily based on the type of blood cells affected and the speed of disease progression. It is divided into two main categories: acute and chronic, which refer to the rapidity of the disease's onset and progression. Additionally, leukemia can be categorized by the type of cell involved, such as lymphocytic (affecting lymphocytes) or myeloid (affecting myeloid cells). This results in four main types: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML).
Myelofibrosis is classified as a myeloproliferative neoplasm (MPN), which is a group of disorders characterized by the overproduction of blood cells. While not classified as leukemia itself, myelofibrosis can lead to secondary acute myeloid leukemia (AML) in some patients. It primarily affects the bone marrow, leading to fibrosis and impaired blood cell production, which can result in anemia, splenomegaly, and other complications. Thus, myelofibrosis is related to leukemia but is distinct in its classification.
Dionne Elise Laslo has written: 'The relation between child coping, parent coping and psychosocial adjustment in children and adolescents with acute lymphocytic leukemia' -- subject(s): Chronically ill children, Family relationships, Lymphocytic leukemia, Parents, Psychological aspects, Psychological aspects of Lymphocytic leukemia, Psychology, Treatment
Donald Pinkel has written: 'Treatment of acute lymphocytic leukemia' -- subject(s): Antineoplastic agents, Chemotherapy, Lymphoblastic leukemia in children
The uric acid does not effect the leukemia however the treatment of leukemia leads to the production of uric acid which in turn can leas to kidney stones and other problems.
It depends on whether its acute or chronic and at what stage it is. The chronic form is usually slower progressing and has a better prognosis.
* Acute lymphocytic leukemia (ALL): 66.1 percent overall; 91.2 percent for children under 5 * Chronic lymphocytic leukemia (CLL): 76.2 percent * Acute myelogenous leukemia (AML): 21.3 percent overall; 55.2 percent for children under 15 * Chronic myelogenous leukemia (CML): 46.7 percent This is the survival rate.....NOT THE DEATH RATE.
The main types of leukemia are classified into four primary categories: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Acute leukemias, such as ALL and AML, progress rapidly, while chronic leukemias, including CLL and CML, typically develop more slowly. Each type has distinct characteristics, treatment approaches, and prognoses.
It really depends on the type of leukemia. But there are several generalizations one can make across the board for all types. Leukemia reflects an unregulated accumulation of immature cells in the bone marrow and lymph tissue. WBC's typically >50,000 per cubic millimeter Shift to the Left # Acute myelocytic leukemia - increased blasts, increased pros and increased segs # Acute lymphocytic leukemia - Increased L-blasts, increased L-pros and no increased segs # Chronic myelocytic leukemia - presence of metas or myelos and increased segs # Chronic lymphocytic leukemia - presence of metas or myelos and no increased segs There are the basics.
In the ICD-9 coding system, leukemia is primarily classified under the codes 204.0 to 208.9, depending on the specific type of leukemia. For example, 204.0 is used for acute lymphoblastic leukemia, while 204.1 pertains to acute myeloid leukemia. Other types, such as chronic lymphocytic leukemia and chronic myeloid leukemia, have their own specific codes within this range. It's important to select the correct code based on the specific diagnosis.